PDA

View Full Version : CalbaTech's Subsidiary, LifeStem, Inc. Files Provisional Patent Application for Stem



Leif
11-01-2005, 09:57 AM
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-01-2005/0004204776&EDATE=



IRVINE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- CalbaTech, Inc.
(OTC Bulletin Board: CLBE), an emerging life sciences company
(http://www.CalbaTech.com (http://www.calbatech.com/)) concentrating on providing products and platforms
to the research market for biotech and pharmaceutical companies and to
academic institutions, announced today that its wholly owned subsidiary,
LifeStem, Inc., filed for US Trademark protection for the name of its stem
cell collection service, Stem Cell Microbank, and filed a provisional patent
application on the process of the Stem Cell Microbank for its process of stem
cell banking. LifeStem believes that it will be the first company to focus on
the micro-collection and banking of two different types of stem cells from one
client.
"LifeStem's approach is based on the model that it may not be necessary to
harvest a regenerative therapeutic amount of stem cells at the time of
collection," said CalbaTech CEO James DeOlden. "Our collection service is
unique in that stem cells will be collected in non-invasive, micro-quantities
and cryo-preserved for cellular expansion at the time of use."
LifeStem, in addition to being the first company to focus on the
micro-collection of stem cells, will also be the first company to offer a
collection service that collects and stores two different types of stem cells
for autologous use. "We believe that it is in the client's best interest to
store stem cells from two tissue sources," added LifeStem President Dan
Fulkerson. "By preserving two different types of stem cells on a pre-disease
basis and making the cells available to the client, the client is afforded two
distinct and different stem cell lineages to better suit their particular
situation. The benefit to the client is that LifeStem's Microbank storage
service allows the client to select the best cell source to be expanded based
on the future need."

More on link above.